|
|
|
| home > white papers > Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor - Eppendorf |
|
|
 WHITE PAPERS |
|
Eppendorf
|
|
Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor
|
|
The number of bioprocess applications for microalgae has increased in
recent years, particularly in the fi eld of biofuel production. The
combination of the New Brunswick CelliGen 310 stirred-tank bioreactor
and the DASGIP LED Illumination System creates a bioreactor setup which
is capable of supporting high density microalgal growth. Using the
stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and
intensities can be controlled for optimal support of all types of
chlorophylls and carotenoids. For this study in which high density
culture of up to 1.5 x 107 cells/mL was achieved, the unicellular
freshwater alga, Dunaliella tertiolecta, was used.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
Keele, UK and Matfors, Sweden, 30 March 2020: Cobra Biologics (Cobra), an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet (KI), one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic. Partners in the consortium also include Karolinska University Hospital, Public Health Authority (FoHM), IGEA, Adlego AB and Giessen University.
More info >> |
|
 |
White Papers |
 |
|
Successfully managing the unique demands of cell therapy supply chains
PCI Pharma Services
Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Europe
18-21 October 2020, Barcelona, Spain
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >> |
|
|
|
